BB Biotech AG announced that it will propose a regular dividend of CHF 2.75 per share for the year ended December 31, 2016 at the general assembly on 16 March 2017. This is consistent with a 5% dividend yield applied to the average share price in December 2016, as described in the dividend policy introduced in 2013.